ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Comparative effect of intravenous nalbuphine versus intravenous paracetamol for post-operative obstetric analgesia

Umamaheswara Raju S, Ushasree T S, Harini, Upender Goud.



Abstract
Download PDF Cited by 1 ArticlesPost

Background: Management of the post-operative pain after cesarean section (CS) requires a balance between the pain relief and undesirable side effects of drugs. To improve the post-operative pain management after CS, we compared analgesic efficacy of i.v nalbuphine versus i.v paracetamol for post-operative CS pain.

Aim and Objective: The aim of the study was to compare the efficacy and safety of single-dose intravenous nalbuphine versus intravenous paracetamol for post-operative analgesia CS pain.

Materials and Methods: This was a hospital-based retrospective study in the department of obstetrics, gynecology, among 120 patients of CS. We enrolled 120 patients in our prospective randomized trial after an uneventful elective CS under the spinal anesthesia. Group A patients received i.v paracetamol infusion and Group B patients received i.v nalbuphine on the first complaint of pain. The results were analyzed byt-test; P

Key words: Post-operative pain; Nalbuphine, Paracetamol; Cesarean section







Bibliomed Article Statistics

21
16
35
32
39
43
40
23
23
18
18
5
R
E
A
D
S

15

14

7

17

18

33

11

19

11

15

8

5
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.